A

Arrowhead Pharmaceuticals
D

ARWR

18.570
USD
0.30
(1.64%)
Market Open
Volume
4,877
EPS
-3
Div Yield
-
P/E
-4
Market Cap
2,308,534,638
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    S
    SLDB
    -0.45000
    (-8.46%)
    4.87000 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    More
News

Title: Arrowhead Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.